NZ Rheumatology Research Review Issue 58

In this issue:
  -  RA disease activity and kidney function decline
  -  Leflunomide-associated peripheral neuropathy in NZ
  -  Pain catastrophising negatively impacts drug retention in PsA and axial SpA
  -  VTE risk with tofacitinib vs. anti-TNF in RA with increased CV risk
  -  Serious adverse events after TSR
  -  Gout flares after initiation of treat-to-target allopurinol and febuxostat
  -  Regional differences in clinical phenotypes of axial SpA
  -  Pain reduction with methotrexate in knee OA
  -  Predictive factors and treatment outcomes in difficult-to-treat RA
  -  Alcohol consumption and gout risk in men and women

Please login below to download this issue (PDF)

Subscribe